CompoAtlas

REOXlife Pro iPluz Powder

REOXlife Pro iPluz Powder : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Vaccinium myrtillusVaccinium myrtillus[7 mg,8 gm]Not identified
Tagetes erectaTagetes erecta[80 mg,8 gm]Not identified
Crocus sativusCrocus sativus[5 mg,8 gm]Not identified
Daucus carotaDaucus carota[20 mg,8 gm]Bêta-carotène

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL23046140T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
BRAND8 NUTRACEUTICAL SDN. BHD.
Manufacturer
BRAND8 NUTRACEUTICAL SDN. BHD.
Registration period starting
2023-04-18
Published validity end
2028-04-18

Original register data

View published fields and their variants
Active ingredients
Vaccinium myrtillus[7 mg,8 gm],Tagetes erecta[80 mg,8 gm],Crocus sativus[5 mg,8 gm],Daucus carota[20 mg,8 gm]
Valid until
2028-04-18
Registration date
2023-04-18
Published description
NATURAL PRODUCT
Licence holder
BRAND8 NUTRACEUTICAL SDN. BHD.
Producer
BRAND8 NUTRACEUTICAL SDN. BHD.
Published name
REOXlife Pro iPluz Powder
Published reference
202211159518T
Registration number
MAL23046140T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL23046140T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Daucus carota
    Read the warning, when it applies and the studies cited

    CARROT - DAUCUS CAROTA SUBSP. SATIVUS

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 6,000 μg of beta-carotene, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).

    Sources cited by Health Canada (3)
    • ATBC (Alpha-tocopherol, beta-carotene cancer prevention) study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The New England Journal of Medicine1994;330(15):1029-1035.
    • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 1996;334(18):1150-1155. PubMed Randomised trial
    • Touvier M, Kess E, Clavel-Chapelon F, and Boutron-Rualt MC. Dual association of beta- carotene with risk of tobacco-related cancers in a cohort of French women. Journal of the National Cancer Institute 2005;97(18):1338-1344. PubMed

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “REOXlife Pro iPluz Powder”, https://compoatlas.com/en/supplements/malaysia/MAL23046140T-reoxlife-pro-ipluz-powder, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line